{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Clark",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "96390",
      "recalling_firm": "L'Oreal USA",
      "address_1": "222 Terminal Ave",
      "address_2": "",
      "postal_code": "07066-1317",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0417-2025",
      "product_description": "La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.",
      "product_quantity": "2,226,801 bottles",
      "reason_for_recall": "Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.",
      "recall_initiation_date": "20250305",
      "center_classification_date": "20250509",
      "report_date": "20250521",
      "code_info": "Lot #: MYX46W, Exp 04/30/2025",
      "more_code_info": ""
    }
  ]
}